Cardiff Oncology burns $12M quarterly with only 5 quarters of cash remaining
Cardiff Oncology holds $60.6M in cash against a $12M quarterly burn rate, leaving approximately five quarters of runway through Q1 2027. Annual operating losses of $41.1M and the catastrophic cash depletion timeline create immediate financing pressure for the clinical-stage oncology company.
ViaNews Editorial Team (Markets)•